CR8590A - Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos - Google Patents
Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidosInfo
- Publication number
- CR8590A CR8590A CR8590A CR8590A CR8590A CR 8590 A CR8590 A CR 8590A CR 8590 A CR8590 A CR 8590A CR 8590 A CR8590 A CR 8590A CR 8590 A CR8590 A CR 8590A
- Authority
- CR
- Costa Rica
- Prior art keywords
- protected
- methods
- morphinots
- morphinot
- dienol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Catalysts (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se describen metodos para elaborar aldehidos y cetonas que comprenden permitir que el alcohol primario o secundario correspondiente reaccione en presencia de un acido tricloroisocianurico, un compuesto de Formula R1SR2 y una base.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54271104P | 2004-02-06 | 2004-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8590A true CR8590A (es) | 2007-07-19 |
Family
ID=34860329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8590A CR8590A (es) | 2004-02-06 | 2006-09-01 | Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos |
Country Status (33)
| Country | Link |
|---|---|
| US (6) | US8003793B2 (es) |
| EP (3) | EP2194059A3 (es) |
| JP (1) | JP4963968B2 (es) |
| KR (4) | KR100921695B1 (es) |
| CN (1) | CN1918168B (es) |
| AP (1) | AP2006003716A0 (es) |
| AT (2) | ATE451374T1 (es) |
| AU (1) | AU2005212258B2 (es) |
| BR (1) | BRPI0506607B8 (es) |
| CA (2) | CA2808199C (es) |
| CR (1) | CR8590A (es) |
| CY (2) | CY1108506T1 (es) |
| DE (2) | DE602005009321D1 (es) |
| DK (2) | DK1864987T3 (es) |
| EA (2) | EA012905B1 (es) |
| EC (1) | ECSP066824A (es) |
| ES (2) | ES2338054T3 (es) |
| GE (1) | GEP20084454B (es) |
| HR (2) | HRP20080618T3 (es) |
| IL (2) | IL177281A (es) |
| MA (1) | MA28346A1 (es) |
| MX (1) | MXPA06008931A (es) |
| NO (2) | NO20063989L (es) |
| NZ (2) | NZ548786A (es) |
| PL (2) | PL1711502T3 (es) |
| PT (2) | PT1864987E (es) |
| RS (2) | RS50663B (es) |
| SG (1) | SG150500A1 (es) |
| SI (2) | SI1711502T1 (es) |
| TN (1) | TNSN06248A1 (es) |
| UA (2) | UA88646C2 (es) |
| WO (1) | WO2005077957A2 (es) |
| ZA (1) | ZA200606252B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA012905B1 (ru) | 2004-02-06 | 2010-02-26 | Еуро-Селтик С.А. | Способы получения 3-о-защищенных морфинов и 3-о-защищенных морфинондиенолкарбоксилатов |
| EP2099764B1 (en) * | 2006-09-20 | 2011-07-27 | Mallinckrodt Inc. | Preparation of substituted morphinan-6-ones and salts and intermediates thereof |
| EP2137189B1 (en) * | 2007-03-06 | 2015-05-06 | Mallinckrodt LLC | Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
| US9040726B2 (en) | 2007-03-06 | 2015-05-26 | Mallinckrodt Llc | Process for the preparation of quaternary N-alkyl morphinan alkaloid salts |
| US8148528B2 (en) * | 2008-05-27 | 2012-04-03 | Mallinckrodt Llc | Processes and compounds for the preparation of normorphinans |
| EP2331508B1 (en) | 2008-09-03 | 2014-11-12 | Mallinckrodt LLC | Substituted berbines and processes for their synthesis |
| PH12012502083A1 (en) | 2010-05-10 | 2017-07-26 | Euro Celtique Sa | Manufacturing of active-free granules and tablets comprising the same |
| EP2568965A1 (en) | 2010-05-10 | 2013-03-20 | Euro-Celtique S.A. | Combination of active loaded granules with additional actives |
| US9700508B2 (en) | 2010-05-10 | 2017-07-11 | Euro-Celtique S.A. | Pharmaceutical compositions comprising hydromorphone and naloxone |
| WO2015071380A1 (en) | 2013-11-13 | 2015-05-21 | Euro-Celtique S.A. | Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome |
| MX2018001968A (es) * | 2015-09-30 | 2018-11-09 | Fujifilm Finechemicals Co Ltd | Metodo de produccion de compuestos organicos. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2654756A (en) * | 1949-10-20 | 1953-10-06 | Mallinckrodt Chemical Works | Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone |
| DE902257C (de) | 1951-07-17 | 1954-01-21 | Knoll Ag | Verfahren zur Herstellung von Acylderivaten der Enolform des Codeinons |
| GB1495271A (en) * | 1974-04-10 | 1977-12-14 | Macfarlan Smith Ltd | Dehydrohalogenation of codeinone derivatives |
| US4472253A (en) * | 1981-08-17 | 1984-09-18 | The Florida Board Of Regents On Behalf Of The Florida State University | Process for the preparation of an N-substituted 3-O-alkyl-14-hydroxynormorphinone derivative |
| US5112975A (en) * | 1984-03-27 | 1992-05-12 | Mallinckrodt Specialty Chemicals Company | Preparation of noroxymorphone from morphine |
| SE9003665D0 (sv) * | 1990-11-16 | 1990-11-16 | Kabivitrum Ab | Morphine prodrugs |
| GB9116909D0 (en) * | 1991-08-06 | 1991-09-18 | Salford Ultrafine Chem & Res | Morphine derivatives |
| US5821374A (en) * | 1995-11-21 | 1998-10-13 | Hoffmann-La Roche Inc. | Process for the oxidation of alcohols |
| US5869669A (en) * | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
| GB9713703D0 (en) * | 1997-06-30 | 1997-09-03 | Johnson Matthey Plc | Preparation of opiates |
| US6177567B1 (en) | 1999-10-15 | 2001-01-23 | Boehringer Ingelheim Chemicals, Inc. | Method for preparing oxycodone |
| US6596877B2 (en) * | 2001-10-17 | 2003-07-22 | Novartis Ag | Accelerated process for preparing O-methyl phenols, N-methyl heteroaromatic compounds, and methylated aminophenols |
| EA012905B1 (ru) | 2004-02-06 | 2010-02-26 | Еуро-Селтик С.А. | Способы получения 3-о-защищенных морфинов и 3-о-защищенных морфинондиенолкарбоксилатов |
-
2005
- 2005-02-04 EA EA200601394A patent/EA012905B1/ru not_active IP Right Cessation
- 2005-02-04 JP JP2006552236A patent/JP4963968B2/ja not_active Expired - Lifetime
- 2005-02-04 DE DE602005009321T patent/DE602005009321D1/de not_active Expired - Lifetime
- 2005-02-04 SI SI200530468T patent/SI1711502T1/sl unknown
- 2005-02-04 UA UAA200704105A patent/UA88646C2/uk unknown
- 2005-02-04 CA CA2808199A patent/CA2808199C/en not_active Expired - Lifetime
- 2005-02-04 AT AT07014411T patent/ATE451374T1/de active
- 2005-02-04 DE DE602005018265T patent/DE602005018265D1/de not_active Expired - Lifetime
- 2005-02-04 KR KR1020077025206A patent/KR100921695B1/ko not_active Expired - Lifetime
- 2005-02-04 EP EP09015220A patent/EP2194059A3/en not_active Withdrawn
- 2005-02-04 DK DK07014411.8T patent/DK1864987T3/da active
- 2005-02-04 CA CA2555215A patent/CA2555215C/en not_active Expired - Lifetime
- 2005-02-04 ES ES07014411T patent/ES2338054T3/es not_active Expired - Lifetime
- 2005-02-04 PL PL05712726T patent/PL1711502T3/pl unknown
- 2005-02-04 US US10/588,637 patent/US8003793B2/en active Active
- 2005-02-04 AU AU2005212258A patent/AU2005212258B2/en not_active Expired
- 2005-02-04 PT PT07014411T patent/PT1864987E/pt unknown
- 2005-02-04 AT AT05712726T patent/ATE406372T1/de active
- 2005-02-04 MX MXPA06008931A patent/MXPA06008931A/es active IP Right Grant
- 2005-02-04 PL PL07014411T patent/PL1864987T3/pl unknown
- 2005-02-04 EP EP07014411A patent/EP1864987B1/en not_active Expired - Lifetime
- 2005-02-04 DK DK05712726T patent/DK1711502T3/da active
- 2005-02-04 KR KR1020077025207A patent/KR20070108956A/ko not_active Ceased
- 2005-02-04 BR BRPI0506607A patent/BRPI0506607B8/pt not_active IP Right Cessation
- 2005-02-04 PT PT05712726T patent/PT1711502E/pt unknown
- 2005-02-04 AP AP2006003716A patent/AP2006003716A0/xx unknown
- 2005-02-04 EP EP05712726A patent/EP1711502B1/en not_active Expired - Lifetime
- 2005-02-04 RS RSP-2008/0553A patent/RS50663B/sr unknown
- 2005-02-04 KR KR1020097016500A patent/KR101011460B1/ko not_active Expired - Lifetime
- 2005-02-04 SI SI200530925T patent/SI1864987T1/sl unknown
- 2005-02-04 ES ES05712726T patent/ES2313299T3/es not_active Expired - Lifetime
- 2005-02-04 NZ NZ548786A patent/NZ548786A/en not_active IP Right Cessation
- 2005-02-04 WO PCT/US2005/003390 patent/WO2005077957A2/en not_active Ceased
- 2005-02-04 EA EA200801811A patent/EA016062B1/ru not_active IP Right Cessation
- 2005-02-04 SG SG200900838-4A patent/SG150500A1/en unknown
- 2005-02-04 GE GEAP20059608A patent/GEP20084454B/en unknown
- 2005-02-04 NZ NZ565355A patent/NZ565355A/en not_active IP Right Cessation
- 2005-02-04 RS RSP-2010/0064A patent/RS51317B/sr unknown
- 2005-02-04 HR HR20080618T patent/HRP20080618T3/xx unknown
- 2005-02-04 CN CN2005800040830A patent/CN1918168B/zh not_active Expired - Lifetime
- 2005-04-02 UA UAA200609622A patent/UA87833C2/uk unknown
-
2006
- 2006-07-28 ZA ZA200606252A patent/ZA200606252B/en unknown
- 2006-08-03 IL IL177281A patent/IL177281A/en active IP Right Grant
- 2006-08-04 TN TNP2006000248A patent/TNSN06248A1/fr unknown
- 2006-08-04 MA MA29240A patent/MA28346A1/fr unknown
- 2006-09-01 CR CR8590A patent/CR8590A/es unknown
- 2006-09-05 EC EC2006006824A patent/ECSP066824A/es unknown
- 2006-09-05 KR KR1020067018113A patent/KR100921696B1/ko not_active Expired - Lifetime
- 2006-09-06 NO NO20063989A patent/NO20063989L/no not_active Application Discontinuation
-
2008
- 2008-11-12 CY CY20081101295T patent/CY1108506T1/el unknown
-
2010
- 2010-02-25 CY CY20101100178T patent/CY1109838T1/el unknown
- 2010-03-05 HR HR20100123T patent/HRP20100123T1/hr unknown
- 2010-05-06 IL IL205596A patent/IL205596A/en active IP Right Grant
-
2011
- 2011-07-22 US US13/189,228 patent/US8198444B2/en not_active Expired - Lifetime
-
2012
- 2012-05-15 US US13/472,227 patent/US8685996B2/en not_active Expired - Lifetime
-
2014
- 2014-02-24 US US14/188,430 patent/US8975257B2/en not_active Expired - Lifetime
-
2015
- 2015-03-02 NO NO20150276A patent/NO339083B1/no unknown
- 2015-03-03 US US14/637,129 patent/US9670218B2/en not_active Expired - Fee Related
-
2017
- 2017-05-04 US US15/587,118 patent/US20170233400A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY33981A (es) | ?método para preparar compuestos macrocíclicos inhibidores de serina proteasas de hepatitis c?. | |
| CR11618A (es) | Inhibidores macrocíclicos de serina proteasa | |
| CY1118332T1 (el) | Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξamιδο-πυριδιno βενζοϊκων οξεων | |
| HN2006000668A (es) | Compuestos de quinolina heteroaromaticos | |
| CL2012002464A1 (es) | Proceso para la preparación de compuestos pesticidas que contienen un grupo tio-triazolo, que comprende hacer reaccionar un compuesto triazolo con un reactivo de grignard; compuestos pesticidas que contienen un grupo tio-triazolo; y su uso. | |
| CR11241A (es) | Compuestos de pirazol y su uso como inhibidores de raf | |
| ATE479687T1 (de) | Kinaseinhibitoren | |
| CO6531429A2 (es) | Inhibidores de la tirosina quinasa de bruton | |
| CL2012000887A1 (es) | Mezcla fungicida sinergica que comprende fluorocitosina y otros compuestos fungicos; composicion fungicida que comprende dicha mezcla y un adyuvante agricolamente aceptable o portador. | |
| CL2008001693A1 (es) | Compuestos derivados de piridil-pirimidinil-amino; composicion fungicida que comprende a dichos compuestos; y metodo para controlar los hongos fitopatogenos de los cultivos; y compuesto intermediario. | |
| CO6382079A2 (es) | Composiciones insecticidas estables a base de sulfoximina | |
| ECSP077984A (es) | Formulacion de un inhibidor de agregacion de plaquetas de tienopiridina | |
| CR10156A (es) | Metodos para preparar alcoholes sulfonamida sustituidos e intermediarios de estos | |
| GT200800251A (es) | Nitrilos espirociclicos como inhibidores de proteasa | |
| ECSP11011494A (es) | Preparación de solido | |
| CR8590A (es) | Metodos para elaborar morfinotas 3-0 protegidas carboxilatos de dienol, morfinota 3-0 protegidos | |
| UY32424A (es) | Comprimidos conteniendo elivitegravir para tratamiento de infecciones virales | |
| EA200702464A1 (ru) | Способы получения фенольных 4-бифенилилазетидин-2-онов | |
| AR064955A1 (es) | Composicion y metodo para estabilizar ingredientes sensibles | |
| CR20120117A (es) | Métodos para la propagación vegetativa de gramíneas | |
| BRPI0514584A (pt) | método para preparar irbesartan e intermediários do mesmo | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| CL2012001248A1 (es) | Compuestos de amidoacetonitrilo que tiene actividad pesticida; uso de dicho compuesto para el control de parasitos en animales de sangre caliente. | |
| EA201400655A1 (ru) | Микробицидная композиция | |
| ATE517890T1 (de) | Verfahren zur herstellung von reinem irbesartan |